CorpDev.Org

Deal Intelligence Platform & Services for Global M&A / PE

Once-in-a-Generation Chemicals Crisis Upends Private Equity Firm’s Bet

Once-in-a-Generation Chemicals Crisis Upends Private Equity Firm’s Bet


TL;DR

SK Capital Partners' 2019-vintage chemicals fund reported a net IRR of -0.35% as of late 2025, with portfolio companies like Venator Materials filing for bankruptcy and Ascend Performance Materials being transferred to creditors. This distress is driven by a structural crisis combining high European energy costs, Chinese overcapacity, and new regulations like the Carbon Border Adjustment Mechanism (CBAM), which priced its first certificates at €75.36 per tonne. The crisis marks the breakdown of the traditional 'buy-and-leverage' private equity model for commodity chemicals, proving that geopolitical and energy security risks can now completely override financial engineering in industrial investment theses.


Deal Post-Mortem

Primary Firm Profiled
SK Capital Partners
Distressed Fund
2019-vintage chemicals-heavy fund
Fund Performance
-0.35% Net IRR (as of late 2025)
Peer Group Median IRR
13.9%
Failure Mode
Structural sector crisis rendering 'buy-and-build' thesis ineffective.
Root Causes
High European energy costs, Chinese capacity glut, and EU regulatory costs (CBAM).
Distressed Asset 1
Venator Materials (Filed for Chapter 11 bankruptcy in 2023)
Distressed Asset 2
Ascend Performance Materials (Control transferred to creditors in 2025)
Distressed Asset 3
SI Group (Handed over to lenders)
Broader Market Signal
Advent International delayed its 2026 purchase option for a 40.94% stake in Envalior from LANXESS.

The global chemicals sector, long a cornerstone of industrial private equity, is grappling with a structural “once-in-a-generation” crisis that has blindsided even the most seasoned specialist investors. As of mid-2026, a toxic combination of high energy costs in Europe, persistent overcapacity in China, and a sharp downturn in key end-markets like automotive and construction has pushed several high-profile private equity holdings into financial distress.

Most “AI for Diligence” tools are lying to you. The truth is, they are just ChatGPT wrappers. Experience what real AI for Diligence looks like, built like Claude Code, but for M&A/ PE Diligence:

💼 When Claude Code Marries Due Diligence!

The fallout is most visible at SK Capital Partners, a $10 billion firm renowned for its sector-specific expertise. Recent filings and market reports indicate that a wave of the firm’s legacy holdings have entered restructuring or been handed over to creditors. This shift highlights a broader industry trend: the breakdown of the traditional “buy-and-build” thesis for commodity and specialty chemicals in a world of fragmented energy pricing and geopolitical volatility.

The Structural Squeeze: Why This Crisis is Different

Unlike previous cyclical downturns, the current malaise in the chemicals industry is being categorized by analysts at firms like Oliver Wyman and Kearney as structural rather than cyclical. Three primary factors are driving this shift:

  • The Energy Arbitrage Collapse: European producers, historically reliant on Russian gas, now face energy costs that remain three to four times higher than those in the U.S. and Asia. This has rendered energy-intensive manufacturing in clusters like Rotterdam and Ludwigshafen fundamentally uncompetitive.
  • The China Capacity Glut: Chinese producers have prioritized market share over profitability, flooding global markets with cheap commodity chemicals (olefins, polymers, and intermediates) at prices that Western plants cannot match.
  • Regulatory Headwinds: The European Union’s tightening emissions trading rules and the rollout of the Carbon Border Adjustment Mechanism (CBAM)—which saw its first official certificate price set at €75.36 per tonne in Q1 2026—have added layers of cost that private equity-backed firms, often heavily levered, struggle to absorb.

Case Study: SK Capital’s Portfolio Under Pressure

The distress within SK Capital’s portfolio serves as a bellwether for the sector. While the firm has seen success in recent healthcare-focused vehicles, its 2019-vintage chemicals-heavy fund reported a net Internal Rate of Return (IRR) of -0.35% as of late 2025—sharply underperforming the 13.9% median for its peer group.

Portfolio Company Status / Development (May 2026) Sub-Sector
Archroma Secured last-minute extension on $1B debt; terms sweetened for creditors. Textile & Paper Chemicals
Venator Materials Filed for Chapter 11 bankruptcy (2023); equity interest largely wiped out. Titanium Dioxide & Pigments
Ascend Performance Materials Control transferred to creditors in 2025 amid nylon market slump. Nylon / Polyamide 6.6
SI Group Handed over to lenders following sustained margin compression. Performance Additives

Market Sentiment and M&A Outlook

The distress is not isolated to SK Capital. Advent International recently opted not to proceed with its 2026 purchase option for a 40.94% stake in Envalior from LANXESS, citing unfavorable financing conditions and the need to adjust the valuation safety margin. This delay underscores the caution permeating the 2026 chemicals M&A landscape.

Investment professionals are now pivoting toward private equity exit strategies in SaaS and healthcare to offset industrial losses, as the “technical ground” for manufacturing deals becomes increasingly treacherous. For those remaining in chemicals, the focus has shifted from expansionary M&A to cross-border M&A trends 2026 that prioritize “operational alpha”—improving manufacturing productivity and procurement efficiency over simple multiple expansion.

The Path Forward: Carve-outs and Specialization

Despite the gloom, strategic realignment is creating new opportunities. Majors like BASF and Bayer continue to shed non-core assets to simplify corporate structures. For private equity firms, the remaining value lies in high-margin specialties linked to semiconductor manufacturing, agriculture, and green technology.

However, the window for simple “buy-and-leverage” strategies in basic chemicals appears closed. As noted by industry analysts, unless there is a dramatic correction in European energy policy or a stabilization of Chinese output, the sector’s structural decline will continue to test the limits of private equity’s ability to “fix and flip” industrial assets in a volatile global economy.

Daily M&A/PE News In 5 Min

Executive Summary: The chemicals crisis of 2026 has exposed the risks of sector-specific concentration in private equity. Dealmakers must now navigate a landscape where energy security and geopolitical alignment are as critical to the investment thesis as EBITDA multiples.

Sources 
 financialpost.com 
 echemi.com 
 kearney.com 
 cbh.com

Frequently Asked Questions

Why is the current crisis in the chemicals sector considered structural, not cyclical?

Analysts at firms like Oliver Wyman and Kearney categorize the crisis as structural due to three persistent factors. First, the collapse of the energy arbitrage has left European producers with energy costs three to four times higher than in the U.S. and Asia. Second, a massive capacity glut from China is flooding global markets with cheap commodity chemicals, suppressing prices. Finally, mounting regulatory costs from the EU's emissions trading rules and the Carbon Border Adjustment Mechanism (CBAM) are adding a layer of expense that leveraged companies cannot absorb, making the downturn a fundamental shift rather than a temporary cycle.

How has SK Capital's portfolio been affected by the chemicals downturn?

SK Capital's portfolio has been severely impacted, serving as a bellwether for the sector's distress. Its 2019-vintage chemicals fund posted a -0.35% net IRR as of late 2025. Specific portfolio companies have entered restructuring, with Venator Materials filing for Chapter 11 bankruptcy, and control of both Ascend Performance Materials and SI Group being handed over to creditors. This demonstrates a widespread failure of the firm's legacy chemical investments amid the current structural crisis.

What were the key financial metrics showing the underperformance of SK Capital's fund?

The primary indicator of underperformance is the net Internal Rate of Return (IRR) of SK Capital's 2019-vintage chemicals-heavy fund. As of late 2025, the fund reported a net IRR of -0.35%. This figure stands in stark contrast to the median IRR for its peer group, which was 13.9%. This significant underperformance highlights the acute impact of the sector's structural crisis on the firm's specialized investment strategy.

What does the crisis mean for the future of private equity M&A in the chemicals industry?

The crisis signals the end of the simple 'buy-and-leverage' and 'buy-and-build' strategies for basic and commodity chemicals. The M&A outlook is now cautious, as shown by Advent International's decision to delay its Envalior stake purchase. Future private equity activity will likely focus on high-margin specialties linked to resilient end-markets like semiconductors and green technology, or on operational turnarounds ('operational alpha') rather than financial engineering. The key takeaway is that energy security and geopolitics have become critical diligence items.

Which specific companies in SK Capital's portfolio faced restructuring or creditor takeovers?

Several of SK Capital's portfolio companies have faced severe financial distress. Venator Materials, a producer of titanium dioxide, filed for Chapter 11 bankruptcy in 2023, wiping out equity. Ascend Performance Materials, a nylon producer, saw control transferred to its creditors in 2025. Similarly, SI Group, a performance additives company, was handed over to its lenders. Another holding, Archroma, secured a last-minute debt extension by offering sweetened terms to its creditors.